Array Digital Infrastructure Inc

18 days ago · defenseworld.net

BlackRock Inc. bought a new stake in Array Digital Infrastructure Inc. (NYSE: AD) in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund bought 400,915 shares of the company's stock, valued at approximately $14,537,000. BlackRock Inc. owned 0.46% of Array Digital Infrastructure

1 month ago · zacks.com

Array Digital Infrastructure beat Q2 estimates as site rental revenues surge 95%, while spectrum sales boost gains and 2026 guidance.

2 months ago · zacks.com

AD, OPTU and T are likely to ride long-term gains from 5G momentum and rising demand for wireless connectivity despite near-term headwinds.

2 months ago · businesswire.com

CAMBRIDGE, Mass.--(BUSINESS WIRE)--LAPIX Therapeutics has appointed Abbas Kazimi, Chief Executive Officer of Nimbus Therapeutics, to its Board of Directors as the Company advances its TIM 3/4 agonist program through Phase 1b clinical trials in rheumatoid arthritis (RA) and atopic dermatitis (AD). Kazimi brings more than two decades of biotechnology leadership experience spanning company building, corporate strategy, financing, and drug development. As CEO of Nimbus Therapeutics, he has overseen.

3 months ago · globenewswire.com

FORT LAUDERDALE, Fla., June 23, 2026 (GLOBE NEWSWIRE) -- AD Mortgage , a leading wholesale lender in the United States, today released findings from its latest broker survey,  Non-QM Fuels Mortgage Industry in 2026  revealing strong momentum for Non-QM lending across the mortgage industry.

3 months ago · globenewswire.com

VANCOUVER, British Columbia, June 18, 2026 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc., a Vancouver-based biopharmaceutical company focused on skin health and longevity, today announced positive preclinical results for its novel small molecule, DB-006. The compound demonstrated high efficacy in treating atopic dermatitis (AD), significantly reducing key disease drivers, including pruritus (itch), epithelial thickening, inflammation, and immunoglobulin E (IgE) levels.

3 months ago · gurufocus.com

On June 10, 2026, Array Digital Infrastructure Inc (AD) shares rose 3.1% to a current price of $52.35. The stock has fluctuated within a 52-week range of $44.03

4 months ago · gurufocus.com

Fosun Pharma and AriBio Sign Exclusive Global Option Agreement for AR1001 for the Treatment of Alzheimer's Disease PR Newswire

4 months ago · zacks.com

Array Digital's Q1 revenues jump 93% on tower leasing growth, but earnings and revenues miss estimates as spectrum deals boost profitability.

4 months ago · zacks.com

TMUS, AD and LILA are likely to ride long-term gains from 5G momentum and rising demand for wireless connectivity despite near-term headwinds.